This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Giorgio Raimondi
Introduction
Giorgio Raimondi is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of immunology through his innovative work on artificial antigen-presenting cells. His research focuses on developing biodegradable particles that can enhance immune responses, particularly in the treatment of autoimmune diseases.
Latest Patents
Giorgio Raimondi holds a patent for "Tolerogenic artificial antigen-presenting cells." This patent describes a biodegradable particle that comprises a polyester or polyester blend, a first protein that binds to an immune cell, and a second protein that promotes proliferation and/or activation of immune cells. Additionally, it includes a third soluble protein or small molecule encapsulated within the particle. The second protein is a fusion protein that consists of at least a portion of an antibody and at least a portion of a cytokine, known as an immunocytokine. The patent also outlines methods for treating diseases or conditions in subjects, such as autoimmune diseases, by administering the biodegradable particle.
Career Highlights
Throughout his career, Giorgio Raimondi has worked with prestigious institutions, including Johns Hopkins University and the United States Department of Health and Human Services. His work has contributed to advancements in medical treatments and has the potential to improve patient outcomes in various autoimmune conditions.
Collaborations
Giorgio has collaborated with notable colleagues, including Marcos Iglesias Lozano and Randall A Meyer. These collaborations have further enriched his research and development efforts in the field of immunology.
Conclusion
Giorgio Raimondi's innovative work in developing tolerogenic artificial antigen-presenting cells showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of autoimmune diseases and improve the quality of life for many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile